annual EBITDA:
-$42.56M-$19.56M(-84.99%)Summary
- As of today (July 7, 2025), CAPR annual EBITDA is -$42.56 million, with the most recent change of -$19.56 million (-84.99%) on December 31, 2024.
- During the last 3 years, CAPR annual EBITDA has fallen by -$21.87 million (-105.70%).
- CAPR annual EBITDA is now -1531.04% below its all-time high of $2.97 million, reached on December 31, 2017.
Performance
CAPR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$24.58M-$17.26M(-235.66%)Summary
- As of today (July 7, 2025), CAPR quarterly EBITDA is -$24.58 million, with the most recent change of -$17.26 million (-235.66%) on March 31, 2025.
- Over the past year, CAPR quarterly EBITDA has dropped by -$14.64 million (-147.40%).
- CAPR quarterly EBITDA is now -297.88% below its all-time high of $12.42 million, reached on December 31, 2017.
Performance
CAPR quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$55.78M-$14.64M(-35.59%)Summary
- As of today (July 7, 2025), CAPR TTM EBITDA is -$55.78 million, with the most recent change of -$14.64 million (-35.59%) on March 31, 2025.
- Over the past year, CAPR TTM EBITDA has dropped by -$30.79 million (-123.23%).
- CAPR TTM EBITDA is now -1975.36% below its all-time high of $2.97 million, reached on December 31, 2017.
Performance
CAPR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CAPR EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -85.0% | -147.4% | -123.2% |
3 y3 years | -105.7% | -217.6% | -139.2% |
5 y5 years | -462.9% | -1084.7% | -552.0% |
CAPR EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -105.7% | at low | -2424.1% | at low | -142.4% | at low |
5 y | 5-year | -462.9% | at low | -2424.1% | at low | -552.0% | at low |
alltime | all time | -1531.0% | at low | -297.9% | at low | -1975.4% | at low |
CAPR EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$24.58M(+235.7%) | -$55.78M(+35.6%) |
Dec 2024 | -$42.56M(+85.0%) | -$7.32M(-42.1%) | -$41.14M(+18.2%) |
Sep 2024 | - | -$12.65M(+12.6%) | -$34.79M(+21.1%) |
Jun 2024 | - | -$11.23M(+13.1%) | -$28.73M(+15.0%) |
Mar 2024 | - | -$9.93M(+920.3%) | -$24.99M(+8.6%) |
Dec 2023 | -$23.01M(-21.1%) | -$973.70K(-85.2%) | -$23.01M(-23.1%) |
Sep 2023 | - | -$6.59M(-12.1%) | -$29.91M(+0.8%) |
Jun 2023 | - | -$7.49M(-5.8%) | -$29.66M(+1.0%) |
Mar 2023 | - | -$7.95M(+1.0%) | -$29.38M(+0.7%) |
Dec 2022 | -$29.16M(+40.9%) | -$7.87M(+24.2%) | -$29.16M(+5.7%) |
Sep 2022 | - | -$6.34M(-12.1%) | -$27.59M(+8.2%) |
Jun 2022 | - | -$7.21M(-6.8%) | -$25.50M(+9.3%) |
Mar 2022 | - | -$7.74M(+22.8%) | -$23.32M(+12.7%) |
Dec 2021 | -$20.69M(+52.8%) | -$6.30M(+48.3%) | -$20.69M(+11.7%) |
Sep 2021 | - | -$4.25M(-15.5%) | -$18.53M(+2.0%) |
Jun 2021 | - | -$5.03M(-1.6%) | -$18.16M(+9.5%) |
Mar 2021 | - | -$5.11M(+23.5%) | -$16.58M(+22.4%) |
Dec 2020 | -$13.55M(+79.1%) | -$4.14M(+6.7%) | -$13.55M(+24.9%) |
Sep 2020 | - | -$3.88M(+12.2%) | -$10.85M(+26.8%) |
Jun 2020 | - | -$3.46M(+66.6%) | -$8.56M(+20.1%) |
Mar 2020 | - | -$2.07M(+44.0%) | -$7.12M(-5.8%) |
Dec 2019 | -$7.56M(-50.2%) | -$1.44M(-9.1%) | -$7.56M(-19.4%) |
Sep 2019 | - | -$1.58M(-21.6%) | -$9.38M(-21.3%) |
Jun 2019 | - | -$2.02M(-19.5%) | -$11.93M(-15.0%) |
Mar 2019 | - | -$2.51M(-23.0%) | -$14.03M(-7.5%) |
Dec 2018 | -$15.17M(-610.0%) | -$3.26M(-21.0%) | -$15.17M(-3054.7%) |
Sep 2018 | - | -$4.13M(+0.2%) | $513.40K(-75.0%) |
Jun 2018 | - | -$4.12M(+12.9%) | $2.05M(-27.9%) |
Mar 2018 | - | -$3.65M(-129.4%) | $2.84M(-4.4%) |
Dec 2017 | $2.97M(-116.2%) | $12.42M(-578.8%) | $2.97M(-121.5%) |
Sep 2017 | - | -$2.59M(-22.1%) | -$13.83M(-15.9%) |
Jun 2017 | - | -$3.33M(-5.5%) | -$16.44M(-7.1%) |
Mar 2017 | - | -$3.52M(-19.6%) | -$17.69M(-3.5%) |
Dec 2016 | -$18.34M(+46.7%) | -$4.38M(-15.9%) | -$18.34M(+6.6%) |
Sep 2016 | - | -$5.21M(+13.7%) | -$17.21M(+16.1%) |
Jun 2016 | - | -$4.58M(+9.8%) | -$14.82M(+11.6%) |
Mar 2016 | - | -$4.17M(+28.2%) | -$13.28M(+6.2%) |
Dec 2015 | -$12.50M(+109.2%) | -$3.25M(+15.2%) | -$12.50M(+12.6%) |
Sep 2015 | - | -$2.82M(-7.0%) | -$11.10M(+13.8%) |
Jun 2015 | - | -$3.04M(-10.5%) | -$9.75M(+19.1%) |
Mar 2015 | - | -$3.39M(+82.8%) | -$8.19M(+37.0%) |
Dec 2014 | -$5.97M(-32.2%) | -$1.85M(+26.0%) | -$5.97M(-28.8%) |
Sep 2014 | - | -$1.47M(+0.2%) | -$8.39M(-0.5%) |
Jun 2014 | - | -$1.47M(+24.7%) | -$8.44M(-1.6%) |
Mar 2014 | - | -$1.18M(-72.4%) | -$8.58M(-2.6%) |
Dec 2013 | -$8.81M(+329.4%) | -$4.27M(+182.0%) | -$8.81M(+79.8%) |
Sep 2013 | - | -$1.52M(-5.9%) | -$4.90M(+24.1%) |
Jun 2013 | - | -$1.61M(+14.5%) | -$3.95M(+106.3%) |
Mar 2013 | - | -$1.41M(+285.9%) | -$1.91M(+49.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2012 | -$2.05M(-58.0%) | -$364.70K(-35.4%) | -$1.28M(-50.4%) |
Sep 2012 | - | -$564.80K(-233.5%) | -$2.57M(-18.3%) |
Jun 2012 | - | $423.00K(-154.9%) | -$3.15M(-29.2%) |
Mar 2012 | - | -$770.10K(-53.7%) | -$4.45M(-8.7%) |
Dec 2011 | -$4.88M(-22.3%) | -$1.66M(+45.6%) | -$4.88M(+14.6%) |
Sep 2011 | - | -$1.14M(+30.0%) | -$4.26M(-13.6%) |
Jun 2011 | - | -$878.40K(-26.5%) | -$4.92M(-11.2%) |
Mar 2011 | - | -$1.20M(+14.9%) | -$5.54M(-11.7%) |
Dec 2010 | -$6.28M(-18.7%) | -$1.04M(-42.5%) | -$6.28M(-7.5%) |
Sep 2010 | - | -$1.81M(+20.8%) | -$6.79M(-2.6%) |
Jun 2010 | - | -$1.50M(-22.5%) | -$6.97M(-12.3%) |
Mar 2010 | - | -$1.93M(+24.9%) | -$7.95M(+2.9%) |
Dec 2009 | -$7.72M(-41.9%) | -$1.55M(-22.3%) | -$7.72M(-15.6%) |
Sep 2009 | - | -$1.99M(-19.5%) | -$9.15M(-12.9%) |
Jun 2009 | - | -$2.47M(+44.6%) | -$10.50M(-11.4%) |
Mar 2009 | - | -$1.71M(-42.4%) | -$11.85M(-10.8%) |
Dec 2008 | -$13.29M(+40.3%) | -$2.97M(-11.2%) | -$13.29M(+2.0%) |
Sep 2008 | - | -$3.35M(-12.4%) | -$13.02M(-9.0%) |
Jun 2008 | - | -$3.82M(+21.2%) | -$14.31M(+20.1%) |
Mar 2008 | - | -$3.15M(+16.6%) | -$11.91M(+25.8%) |
Dec 2007 | -$9.47M(+279.2%) | -$2.70M(-41.6%) | -$9.47M(+29.1%) |
Sep 2007 | - | -$4.63M(+225.2%) | -$7.34M(+110.3%) |
Jun 2007 | - | -$1.42M(+100.1%) | -$3.49M(+69.8%) |
Mar 2007 | - | -$711.90K(+25.7%) | -$2.05M(+52.2%) |
Dec 2006 | -$2.50M(>+9900.0%) | -$566.20K(-27.9%) | -$1.35M(+70.7%) |
Sep 2006 | - | -$785.10K(-8823.3%) | -$790.40K(+8985.1%) |
Jun 2006 | - | $9000.00(-225.0%) | -$8700.00(-57.8%) |
Mar 2006 | - | -$7200.00(+1.4%) | -$20.60K(+9.6%) |
Dec 2005 | -$18.90K(-0.5%) | -$7100.00(+108.8%) | -$18.80K(-14.2%) |
Sep 2005 | - | -$3400.00(+17.2%) | -$21.90K(-0.5%) |
Jun 2005 | - | -$2900.00(-46.3%) | -$22.00K(0.0%) |
Mar 2005 | - | -$5400.00(-47.1%) | -$22.00K(+15.2%) |
Dec 2004 | -$19.00K(+17.3%) | -$10.20K(+191.4%) | -$19.10K(+33.6%) |
Sep 2004 | - | -$3500.00(+20.7%) | -$14.30K(+31.2%) |
Jun 2004 | - | -$2900.00(+16.0%) | -$10.90K(-27.3%) |
Mar 2004 | - | -$2500.00(-53.7%) | -$15.00K(-7.4%) |
Dec 2003 | -$16.20K(-9.0%) | -$5400.00(+5300.0%) | -$16.20K(+11.0%) |
Sep 2003 | - | -$100.00(-98.6%) | -$14.60K(-36.8%) |
Jun 2003 | - | -$7000.00(+89.2%) | -$23.10K(-16.6%) |
Mar 2003 | - | -$3700.00(-2.6%) | -$27.70K(+55.6%) |
Dec 2002 | -$17.80K(-19.8%) | -$3800.00(-55.8%) | -$17.80K(+6.0%) |
Sep 2002 | - | -$8600.00(-25.9%) | -$16.80K(+30.2%) |
Jun 2002 | - | -$11.60K(-287.1%) | -$12.90K(+87.0%) |
Mar 2002 | - | $6200.00(-321.4%) | -$6900.00(-68.9%) |
Dec 2001 | -$22.20K(-38.8%) | -$2800.00(-40.4%) | -$22.20K(+14.4%) |
Sep 2001 | - | -$4700.00(-16.1%) | -$19.40K(+32.0%) |
Jun 2001 | - | -$5600.00(-38.5%) | -$14.70K(+61.5%) |
Mar 2001 | - | -$9100.00 | -$9100.00 |
Dec 2000 | -$36.30K(<-9900.0%) | - | - |
Dec 1999 | $0.00 | - | - |
FAQ
- What is Capricor Therapeutics, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Capricor Therapeutics, Inc.?
- What is Capricor Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Capricor Therapeutics, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Capricor Therapeutics, Inc.?
- What is Capricor Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Capricor Therapeutics, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Capricor Therapeutics, Inc.?
- What is Capricor Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Capricor Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of CAPR is -$42.56M
What is the all time high annual EBITDA for Capricor Therapeutics, Inc.?
Capricor Therapeutics, Inc. all-time high annual EBITDA is $2.97M
What is Capricor Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, CAPR annual EBITDA has changed by -$19.56M (-84.99%)
What is Capricor Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of CAPR is -$24.58M
What is the all time high quarterly EBITDA for Capricor Therapeutics, Inc.?
Capricor Therapeutics, Inc. all-time high quarterly EBITDA is $12.42M
What is Capricor Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, CAPR quarterly EBITDA has changed by -$14.64M (-147.40%)
What is Capricor Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of CAPR is -$55.78M
What is the all time high TTM EBITDA for Capricor Therapeutics, Inc.?
Capricor Therapeutics, Inc. all-time high TTM EBITDA is $2.97M
What is Capricor Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, CAPR TTM EBITDA has changed by -$30.79M (-123.23%)